Against a backdrop of higher U.S. stocks and a weaker yen, corporate developments were reported including buybacks with set limits and upward revisions to dividend forecasts, led by IDEC and ハイデ日高.
Against a backdrop of trends in U.S. equity markets, IDEC raised its earnings forecast for the fiscal year ending March 2027. It also raised its dividend forecast for the fiscal year ending February 2027 and announced a share buyback capped at 3.27% of shares outstanding, along with commissioned purchases. In a related development, ハイデ日高 also raised its dividend forecast for the fiscal year ending February 2027 and announced a similar share buyback and commissioned purchases capped at 3.27% of shares outstanding. Hitachi announced a share buyback capped at 3.56% of shares outstanding.
Nikkei Pharma reportedly entered into exclusive licensing agreements with Italpharmaco, an Italian pharmaceutical company, covering JR-141 in the United States, Europe and Latin America. Denso announced that it would discontinue the acquisition of the spark-plug business and other operations. While some companies reported a recovery in September same-store sales, up 8.8%, stocks such as 瑞光, 象印マホービン, インフロニアHD and 東京ベース, which reported losses for the first half, are also expected to remain weak.